NanoString Posts 55 Percent Revenue Growth for Q4 | GenomeWeb

NEW YORK (GenomeWeb News) – NanoString Technologies reported after the close of the market Wednesday a 55 percent increase in fourth quarter revenues, driven by strong growth for its instruments.

The Seattle-based genetic analysis systems maker reported total revenues of $10.1 million for the three months ended Dec. 31, up from $6.5 million year over year. NanoString beat analysts' consensus estimate for revenues of $9.6 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.